Sponsor
Shanghai 6th People's Hospital
Clinical research sponsor
Clinical trials
32 shownCGM for Insulin-Treated T2DM During Post-Discharge TransitionNCT07414277 · lead sponsor · 2026-05-11
RECRUITINGSalivary Cortisol and Hypercortisolism in Type 2 DiabetesNCT07156370 · lead sponsor · 2025-09-11
RECRUITINGEffect of Continuous Glucose Monitoring System on Glycemic Control in Non-insulin-Treated Elderly People With Type 2 DiabetesNCT07007676 · lead sponsor · 2025-07-14
RECRUITINGEffects of Real-time Continuous Glucose Monitoring System on Hospital-to-home Transitional Blood Glucose ControlNCT06591286 · lead sponsor · 2024-10-25
RECRUITINGA Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic CholangiocarcinomaNCT07632235 · lead sponsor · 2026-09-15
NOT_YET_RECRUITINGClinical Evaluation of Salivary 1,5-Anhydroglucitol in DiabetesNCT07781683 · lead sponsor · 2026-09-01
NOT_YET_RECRUITINGThe CGM-OGTT Glycemic Homeostasis StudyNCT07288372 · lead sponsor · 2025-12-18
NOT_YET_RECRUITINGIntervention Effects of Optimized Carbohydrate Diet in Patients With Type 2 DiabetesNCT06936657 · lead sponsor · 2025-10-20
NOT_YET_RECRUITINGMulti-omics Mechanisms of Lifestyle Intervention in Regulating Blood GlucoseNCT07146308 · lead sponsor · 2025-08-31
COMPLETEDStudy of AI-based Prediction Models for Exercise-Induced Gut Microbiota Alterations in Patients With Type 2 DiabetesNCT06931210 · lead sponsor · 2025-04-18
COMPLETEDEffect of Continuous Glucose Monitoring System Alerts on Diabetes Management in the HospitalNCT05941286 · lead sponsor · 2024-04-18
COMPLETEDCTC in Lung Caner Patients With Bone MetastasesNCT04568291 · lead sponsor · 2020-10-01
UNKNOWNShanghai Community Prediabetes Standardized Management ProjectNCT04256460 · lead sponsor · 2019-12-01
COMPLETEDPeer Support To Enhance The Shanghai Integration Model Of Diabetes Care: Dissemination To 12 CommunitiesNCT03958838 · lead sponsor · 2019-03-30
COMPLETEDPeer Support To Enhance The Shanghai Integration Model Of Diabetes Care: Extension & DisseminationNCT03438617 · lead sponsor · 2017-03-08
COMPLETEDPeer Support in Diabetes Management - Insulin Peer SupportNCT03437525 · lead sponsor · 2017-03-08
COMPLETEDthe Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix InsulinNCT02438397 · lead sponsor · 2014-12-01
UNKNOWNEffect of Paired Testing to Poorly Controlled Chinese Diabetes on Glycemic Control and Self CareNCT02225691 · lead sponsor · 2014-12-01
UNKNOWNMobile Health and Wearable Devices for Diabetes Complication ManagementNCT07129148 · collaborator · 2025-10-01
RECRUITINGExpressions of Ezrin and Pip5k1α Proteins in Airway Smooth Muscle of Asthmatic PatientsNCT06427018 · collaborator · 2024-05-28
RECRUITINGEfficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental DisordersNCT06112067 · collaborator · 2023-10-16
RECRUITINGPARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast CancerNCT05759546 · collaborator · 2023-02-01
RECRUITINGSNF Platform Study of HR+/ HER2-advanced Breast CancerNCT05594095 · collaborator · 2022-12-30
RECRUITINGXinqiao High-risk Cohort of Diabetes(NICE)NCT07281170 · collaborator · 2019-10-08
RECRUITINGThe Effect of Semaglutide on Bone HealthNCT07165158 · collaborator · 2025-09-15
NOT_YET_RECRUITINGPARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast CancerNCT06612814 · collaborator · 2024-09-01
ACTIVE_NOT_RECRUITINGMagnetically Controlled Capsule Endoscope System in Stomach Examination of Moderately and Severely Obese PatientsNCT05459714 · collaborator · 2022-10-15
UNKNOWNImmune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02NCT05205200 · collaborator · 2022-06-06
UNKNOWNA Study of Supaglutide in Chinese Type 2 Diabetes PatientsNCT04314622 · collaborator · 2020-04-14
COMPLETEDThe Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.NCT02942615 · collaborator · 2017-06-27
UNKNOWNExenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 DiabetesNCT02303730 · collaborator · 2015-03-01
COMPLETEDLow Protein Diet Supplemented With Ketoanalogs on Reducing Proteinuria and Maintaining Nutritional Status in Type 2 Diabetic NephropathyNCT01300273 · collaborator · 2011-02-01
UNKNOWNSponsor roles
lead sponsor18
collaborator14
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.